Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06671613 · ClinicalTrials.gov registry record · NA
Evaluating a Fasting-mimicking Diet in Combination With Immunotherapy in Patients With Non-small Cell Lung Cancer
A NA study of NSCLC and Immunotherapy, sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- NA
- Development phase
- 66
- Enrollment target
- 4
- Study locations
NCT06671613: Recruiting NA study of NSCLC and Immunotherapy, sponsored by VA Office of Research and Development.
NCT06671613 is a NA study of NSCLC and Immunotherapy that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 66 participants, below the 223-participant average among 71 other NSCLC trials with a reported enrollment target (70% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06671613, a NA study of NSCLC and Immunotherapy, is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this study is to learn the effects of fasting on cancer cells while you get maintenance treatment.
Primary Outcome
Feasibility will be defined as the proportion of the patients who can finish the 3 cycles FMD without serious adverse events. The investigators define FMD as being a feasible intervention in NSCLC receiving checkpoint inhibitors if 70% of patients on study complete 3 cycles of FMD.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT FMD
- COMBINATION_PRODUCT Regular Diet Plus FMD
Study Locations (4)
California
- VA Long Beach Healthcare System, Long Beach, CA - Long Beach
Illinois
- Jesse Brown VA Medical Center, Chicago, IL - Chicago
Indiana
- Richard L. Roudebush VA Medical Center, Indianapolis, IN - Indianapolis
Missouri
- St. Louis VA Medical Center John Cochran Division, St. Louis, MO - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2025-10-27 |
| Est. Completion | 2030-12-31 |
| Phase | NA |
What NCT06671613 shows while recruiting
NCT06671613 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 223-participant average among 71 other NSCLC trials with a reported enrollment target (70% lower).
The record links to 4 conditions, with NSCLC appearing as the primary indexed condition, and to 2 interventions - of which FMD is the first listed.
NCT06671613 reports a single indexed study location in California, Illinois, Indiana.
Frequently Asked Questions
What is clinical trial NCT06671613 about?
NCT06671613 is a clinical study titled "Evaluating a Fasting-mimicking Diet in Combination With Immunotherapy in Patients With Non-small Cell Lung Cancer". The purpose of this study is to learn the effects of fasting on cancer cells while you get maintenance treatment.
What is the current status of trial NCT06671613?
This trial is currently recruiting. It is a NA study. The enrollment target is 66 participants. The study started on 2025-10-27. Estimated completion is 2030-12-31.
What conditions does trial NCT06671613 study?
This clinical trial studies the following conditions: NSCLC, Immunotherapy, Stage IV NSCLC, Fasting Mimicking Diet.
What interventions are being tested in trial NCT06671613?
The interventions under investigation include: FMD (DIETARY_SUPPLEMENT), Regular Diet Plus FMD (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT06671613?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06671613 being conducted?
This trial has 4 study locations across California, Illinois, Indiana, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for NSCLC
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06671613's enrollment target sits among peer trials
66 53rd of 71 higher than 19 of 71 other NSCLC trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NSCLC trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
RECRUITING · NA
-
LUNG-05: Investigating Chemotherapy Effectiveness for Non-Small Cell Lung Cancer (NSCLC) Metastatic Patients
RECRUITING · NA
-
Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy
RECRUITING · NA
-
A Study of EP0031 in Patients With Advanced RET-altered Malignancies
RECRUITING · Phase 1
-
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
RECRUITING · Phase 1
-
A Study of REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung Cancer
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI